BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 13, 2005
View Archived Issues
Antiarthritic effects of dRK6
Read More
New generation antifolate drugs show promise for methotrexate-resistant RA
Read More
Novel PDE3/4 inhibitors with bronchodilator and antiinflammatory properties reported
Read More
Asoprisnil recruits coactivators to target gene promoters
Read More
AMG-641 shows promising preclinical results for hyperparathyroidism treatment
Read More
Update on the antitumor effects of AMN-107 in hematological malignancies
Read More
Eprosartan shows efficacy in the prevention of secondary stroke
Read More
Promising clinical results reported for Cotara in malignant glioma
Read More
No abuse potential found with ramelteon in humans
Read More
Agomelatine improves the sexual function of male depressed patients
Read More
Target enrollment reached in phase II wet AMD study of Evizon
Read More
New data on the use of TDM to optimize MMF therapy in kidney transplant
Read More
AMDL receives nonsubstantial equivalence letter from the FDA
Read More
Surface Logix studies selective oral PDE5 inhibitor in phase I trial
Read More
Biotest's BT-061 found effective in refractory RA
Read More
AnGes and MedGel to develop innovative antiinflammatory drugs
Read More
Anastrozole studied for postmenopausal women with metastatic breast cancer
Read More
Preclinical study for Avantogen-codeveloped herpes vaccine
Read More
PhosLo studied in chronic kidney disease patients
Read More
Private investment to fund Osiris' three clinical programs
Read More
Positive preclinical results for two new Novavax compounds
Read More
DailyDrugNews.com headline e-mail alerts now contain links
Read More
Diovan receives E.U. marketing authorization for heart failure indication
Read More
Actemra, world's first drug for Castleman's disease launched in Japan
Read More
Temodal approved in Europe for newly diagnosed glioblastoma multiforme
Read More
Alteon discontinues systolic hypertension study of alagebrium
Read More
Japanese launch of Amnolake for APL
Read More
New therapeutics for cancer disclosed in recent patents
Read More
New treatments for obesity and other metabolic disorders disclosed
Read More